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Abstract
Long-term supplementation with folic acid may improve cognitive performance in older individuals. The relationship between folate status
and cognitive performance might be mediated by changes in methylation capacity, as methylation reactions are important for normal
functioning of the brain. Although aberrant DNA methylation has been implicated in neurodevelopmental disorders, the relationship
between DNA methylation status and non-pathological cognitive functioning in human subjects has not yet been investigated. The present
study investigated the associations between global DNA methylation and key domains of cognitive functioning in healthy older adults.
Global DNA methylation, defined as the percentage of methylated cytosine to total cytosine, was measured in leucocytes by liquid
chromatography–MS/MS, in 215 men and women, aged 50–70 years, who participated in the Folic Acid and Carotid Intima-Media Thick-
ness (FACIT) study (clinical trial registration number NCT00110604). Cognitive performance was assessed by means of the Visual Verbal
Word Learning Task, the Stroop Colour-Word Interference Test, the Concept Shifting Test, the Letter–Digit Substitution Test and the
Verbal Fluency Test. Using hierarchical linear regression analyses adjusted for age, sex, level of education, alcohol consumption, smoking
status, physical activity, erythrocyte folate concentration and 5,10-methylenetetrahydrofolate reductase 677 C! T genotype, we found
that global DNA methylation was not related to cognitive performance on any of the domains measured. The present study results do
not support the hypothesis that global DNA methylation, as measured in leucocytes, might be associated with cognitive functioning in
healthy older individuals.
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Most cognitive functioning declines with advancing age,
and identifying the risk factors for age-related cognitive
decline has become a topic of increasing interest. Previous
research has indicated that a low folate status might increase
the risk of cognitive impairment(1). However, the potential
biological mechanisms underlying this relationship remain to
be elucidated.
One possible mechanism that might explain the involve-
ment of folate status in cognitive performance is DNA methyl-
ation, which refers to the epigenetic modification of gene
expression by the addition of methyl groups to cytosine
residues in DNA(2). Recent studies on animals have suggested
that DNA methylation may be involved in regulating synaptic
plasticity in hippocampal neurons, thereby influencing
learning and memory processes(3,4). In humans, both hypo-
methylation and hypermethylation of DNA have been impli-
cated in psychiatric disorders, including schizophrenia(5);
neurodegenerative disorders, such as Alzheimer’s disease(6);
and syndromes associated with mental retardation, e.g. Fragile
X syndrome(7).
Methyl groups for DNA methylation are provided by the
universal methyl donor S-adenosylmethionine, which is
synthesised from methionine(8). Folic acid may increase the
availability of S-adenosylmethionine by promoting the conver-
sion of homocysteine into methionine, thereby influencing
DNA methylation status(9). Indeed, an intervention study in
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older women has shown that low dietary folate intake was
associated with global DNA hypomethylation, which could
be reversed by folate repletion(10). In addition, the common
5,10-methylenetetrahydrofolate reductase (MTHFR) 677C! T
polymorphism, which mimics folate deficiency by impairing
the conversion of homocysteine into methionine, has also
been related to DNA hypomethylation(11).
Given the role of folate metabolism in generating methyl
donors for methylation processes, and the involvement of
DNA methylation in brain functioning, it seems reasonable
to hypothesise that folate status might influence cognitive
functioning by exerting effects on DNA methylation. However,
the association between DNA methylation status and cognitive
performance in the general population has not yet been
investigated. Therefore, the present study examined whether
leucocyte global DNA methylation was associated with cogni-
tive performance in healthy older adults.
Methods
Study population
The present study was performed using data from the Folic Acid
and Carotid Intima-Media Thickness (FACIT) study, a random-
ised, double-blinded, placebo-controlled trial, originally
designed to investigate the effects of 3-year folic acid sup-
plementation on the risk of CVD(12). The study population con-
sisted of 818 healthy men and women, aged 50–70 years at
baseline. A detailed description of the study design and the
selection of participants can be found elsewhere(12).
Venous blood samples were collected at baseline. Leucocyte
global DNA methylation was determined in a sub-sample of
216 participants. First, the study population was stratified by
MTHFR 677 C! T genotype, to ensure equal distribution of
MTHFR 677 C! T genotypes in the final sample. Thereafter,
participants in the folate treatment group were randomly
selected from the three strata and were individually matched
with participants in the placebo group on the variables age,
sex, smoking status and MTHFR 677C! T genotype, as these
variables may influence DNA methylation(11,13,14). Some
samples were not measured due to human error in sample
retrieval. Valid DNA methylation data were available for 111
participants in the treatment group and 105 participants in
the placebo group. As valid data on cognitive functioning
were lacking for one participant in the folate treatment
group, the final study sample consisted of 215 individuals.
This study was conducted according to the guidelines
laid down in the Declaration of Helsinki and all procedures
involving human participants were approved by the Medical
Ethics Committee of Wageningen University. Written informed
consent was obtained from all the participants.
Cognitive functioning
Cognitive functioning on the domains of memory, sensorimo-
tor speed, complex speed, information processing speed
and word fluency was assessed by a comprehensive neuro-
psychological test battery, consisting of the Visual Verbal
Word Learning Task, the Stroop Colour-Word Interference
Test, the Concept Shifting Test, the Letter–Digit Substitution
Test and the Verbal Fluency Test, as described earlier(12).
DNA methylation status and genotyping
Genomic DNA was isolated from peripheral blood leucocytes
at baseline. Global DNA methylation was determined by liquid
chromatography-MS/MS, as described previously(15). Genomic
DNA methylation status was calculated as the percentage
of methylated cytosine to total cytosine (mCyt/tCyt) using
the following formula(15): (nmol mCyt/(nmol mCyt þ nmol
Cyt)) £ 100 %.
MTHFR 677 C! T genotype was determined by PCR
with restriction fragment length polymorphism analysis with
HinfI(16), and was defined as a common variant (CC or CT
genotype) or a rare variant (TT genotype).
Blood measurements
Fasting venous blood samples were collected at baseline, pro-
cessed directly and stored at2808C. Serum folate was measured
using a chemiluminescent immunoassay (Diagnostic Products
Corporation, Los Angeles, CA, USA). Erythrocyte folate was
determined in duplicate and the average was taken to reduce
measurement error. Erythrocyte folate concentrations were
calculated using the following formula: (unadjusted erythro-
cyte folate/haematocrit) 2 ((1 2 haematocrit)/haematocrit) £
serum folate. Plasma total homocysteine was determined by
HPLC and fluorimetric detection, as described previously(17).
Demographic and lifestyle variables
Level of education (low/middle/high) was measured by classi-
fying formal schooling according to the Dutch educational
system(18). Alcohol consumption (g/d) and current smoking
(yes/no) were ascertained by means of self-report question-
naires. BMI (kg/m2) was calculated from height and weight,
and physical activity was estimated using the Physical Activity
Scale for the Elderly(19).
Statistical analysis
Normality of data distributions was ascertained by normal P–P
plots. Baseline data were used to assess the cross-sectional
associations between global DNA methylation status and cog-
nitive functioning. Independent samples t tests and univariate
ANOVA were carried out to examine whether DNA methyl-
ation status varied according to sex, level of education,
smoking status or MTHFR 677 C!T genotype.
Hierarchical linear regression analyses were performed
for DNA methylation status in relation to each of the five
cognitive performance indices. The analyses were corrected
for sociodemographic and lifestyle variables that were con-
sidered potential confounders, i.e. age, sex, level of education,
alcohol consumption, smoking status, physical activity,
erythrocyte folate concentration and MTHFR 677 C! T
genotype(11,13,14,20).
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To investigate the possibility of a non-linear relationship
between global DNA methylation and cognitive performance,
we repeated the analyses with the quadratic term for DNA
methylation status as the independent variable, adjusted for
covariates and the linear term for DNA methylation status.
The quadratic term for DNA methylation status was expressed
as the residuals of regressing (DNA methylation)2 on DNA
methylation, i.e. the quadratic component that is orthogonal
to the linear component of DNA methylation.
The statistical power for detecting associations between
DNA methylation status and each of the dependent variables,
assuming a small effect size of f 2 ¼ 0·03, was 0·80. Statistical
differences were considered significant at P,0·05. All analyses
were performed using SPSS 16.0 (SPSS, Inc., Chicago, IL, USA).
Results
Table 1 summarises the characteristics of the study population.
The percentage of methylated cytosine to total cytosine resi-
dues in leucocyte DNA ranged from 4·0 to 5·6 %, which was
comparable to the range reported by other population-based
studies(11,15). The extent of global DNA methylation did not
vary according to sex (t ¼ 21·285, P¼0·200), level of educa-
tion (F ¼ 0·611, P¼0·544), smoking status (t ¼ 1·611, P¼0·109)
or MTHFR 677C! T genotype (t ¼ 20·907, P¼0·365).
Hierarchical linear regression analyses corrected for age,
sex, level of education, alcohol consumption, smoking
status, physical activity, erythrocyte folate concentration and
MTHFR 677 C! T genotype did not reveal any significant
associations between leucocyte global DNA methylation and
cognitive performance on any of the domains measured
(Table 2). In addition, repeating the analyses with the quadra-
tic term for DNA methylation status as the independent
variable did not yield any significant results (data not
shown), implying that global DNA methylation did not show
a non-linear relationship with cognitive performance.
Discussion
The present study did not support the hypothesis that individ-
ual variation in cognitive functioning in older adults might
be related to the extent of leucocyte global DNA methylation.
Although there are no previous studies investigating the
relationship between global DNA methylation and cognitive
functioning in healthy human subjects, aberrant DNA methyl-
ation has been implicated in neurodevelopmental disorders(7),
psychiatric diseases(5) and neurodegenerative disorders(6).
In addition, animal research has suggested that DNA methyl-
ation status may be involved in learning and memory pro-
cesses, e.g. by regulating synaptic plasticity in hippocampal
neurons(3,4).
The observed lack of a relationship between global DNA
methylation and cognitive performance in healthy adults
might imply that there is no functional relationship between
the extent of cytosine methylation within DNA and individual
differences in cognitive performance in the general popu-
lation. In line with earlier reports(15), we observed that
global DNA methylation has a relatively narrow distribution
in healthy individuals. These findings suggest that under
non-pathological conditions, there appears to be little inter-
individual variation in DNA methylation-based regulation
of gene expression, which decreases the likelihood that indi-
vidual differences in cognitive performances may be mediated
by this epigenetic mechanism.
Although global DNA methylation might not be involved in
cognitive functioning, the present results do not rule out the
possibility that DNA methylation at specific loci may be related
to cognitive performance. In human subjects, gene-specific
alterations in DNA methylation patterns have been associated
with a number of pathological conditions characterised by
cognitive deficits. Animal studies have suggested that diet-
induced folate deficiency may result in overexpression of the
Presenilin 1 gene by causing hypomethylation of its promoter
region(21). Increased expression of this gene, which leads to
elevated production of b-amyloid peptide, has been impli-
cated in the aetiology of Alzheimer’s disease(22). In addition,
schizophrenia has been associated with reduced expression
of the gene encoding the protein Reelin, which is involved
in neurodevelopment and synaptic plasticity, due to hyper-
methylation of the gene’s promoter region(5). However,
although it may be speculated that gene-specific changes in
DNA methylation might underlie part of the individual differ-
ences in non-pathological cognitive functioning, little is known
Table 1. Characteristics of the study population
(Mean values and 95% confidence intervals)
Characteristics Total sample (n 215) 95% CI
Age (years) 60·9 60·2, 61·6
Female sex (%) 34·9
Level of education (% low/middle/high) 26·0/39·1/34·9
Alcohol consumption (g/d)* 12·6 4·5, 23·5
Current smoker (%) 14·9
BMI (kg/m2) 26·7 26·2, 27·2
Physical activity (PASE score) 149·2 140·5, 158·0
Erythrocyte folate (nmol/l) 716·0 681·2, 750·8
Plasma total homocysteine (mmol/l) 13·4 12·9, 13·8
MTHFR 677C! T genotype (% CC/CT/TT) 34·9/32·6/32·6
Leucocyte global DNA methylation status (%)† 4·6 4·6, 4·7
PASE, Physical Activity Scale for the Elderly; MTHFR, 5,10-methylenetetrahydrofolate reductase.
*Median (interquartile range) is given because of skewed data distribution.
†Percentage of methylated to total cytosine.
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about the genetic correlates of cognitive performance in
healthy human subjects.
An alternative explanation for the present null findings is
that cognitive performance might be related to short-term
changes, i.e. within the range of hours, in DNA methylation
patterns rather than individual variation on the level of
global DNA methylation. Indeed, animal studies have reported
that dynamic and reversible changes in DNA methylation,
such as the transient methylation and demethylation of DNA,
are crucial for synaptic plasticity, learning and memory pro-
cesses(3,4). It might be complicated, however, to measure
such short-term changes in DNA methylation in volunteers,
which makes it rather difficult to test this possibility.
From a methodological perspective, the present study was
limited by its cross-sectional nature. In addition, the fact
that we determined global DNA methylation in leucocytes
rather than brain tissue should also be considered a limitation,
as the extent of DNA methylation might differ between
cells derived from the periphery and the brain(23). However,
no direct measures of DNA methylation status in the central
nervous system were available, given the inability to measure
cerebrospinal fluid or brain DNA methylation status in
volunteers.
It might also be argued that because of the relatively small
sample size, the present study might have been underpow-
ered to detect very modest associations. However, it should
be noted that the present study had 80 % power to detect
a 3 % change in the proportion of explained variance, which
may be considered a small effect size(24).
The present study did not support the notion that folate
metabolism might influence cognitive performance through
the mechanism of global DNA methylation, as measured in
leucocytes. In line with the present findings, we found that
long-term supplementation with folic acid, which significantly
improved cognitive performance in the FACIT population(12),
did not have any effect on leucocyte global DNA methylation
status (A. Jung, Y. Smulders, P. Verhoef, F. J. Kok, H. Blom,
R. Kok, E. Schouten, E. Kampman, J. Durga, 2010, unpub-
lished results). This might be explained by the fact that
methylation capacity is not exclusively dependent on folate
status, as methyl groups may also be provided by dietary
intake of methionine, or by betaine-mediated remethylation
of homocysteine(9).
To the best of our knowledge, this is the first study to
investigate the relationship between leucocyte global DNA
methylation and non-pathological cognitive functioning in
healthy older adults. Future studies focusing on gene-specific
DNA methylation patterns or short-term changes in DNA
methylation status might contribute further to identifying the
epigenetic mechanisms involved in cognitive functioning.
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